Rothschild Investment LLC Evolus, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 110 shares of EOLS stock, worth $1,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
110
Previous 10
1000.0%
Holding current value
$1,244
Previous $110,000
1102.73%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EOLS
# of Institutions
166Shares Held
48.9MCall Options Held
57.2KPut Options Held
5.5K-
Perceptive Advisors LLC New York, NY5.15MShares$58.2 Million1.9% of portfolio
-
Tang Capital Management LLC San Diego, CA5MShares$56.5 Million4.14% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$45.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.17MShares$35.9 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.13MShares$35.4 Million1.74% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $634M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...